• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MEM

MEMPHASYS LIMITED. - News & Media

0.00% ! 0.5¢
Market Cap $9.917M  !
Technology Scientific & Technical Instruments
Add to My Watchlist

Memphasys Ltd is a listed Australian MedTech company (ASX: MEM) focussed on reproductive... Memphasys Ltd is a listed Australian MedTech company (ASX: MEM) focussed on reproductive biotechnology. Driven by market needs, Memphasys is developing a portfolio of device, diagnostic and media products that address human and animal reproduction issues.More

Corporate Spotlight

Memphasys Ltd is a listed Australian MedTech company (ASX: MEM) focussed on reproductive biotechnology. Driven by market needs, Memphasys is developing a portfolio of device, diagnostic and media products that address human and animal reproduction issues.
View the full Corporate Spotlight arrow Created with Sketch.

Trial results prove it lifts the guy’s game in IVF

Articles & Videos

Memphasys tech: Trial results prove it lifts the guys' game in IVF

Memphasys reproductive technology is proving a gamechanger in the guys' side of infertility – which is behind half of all conception issues.

24 Mar 2025 10:07 (AEDT)

Publication highlights strengths of Memphasys' antioxidant profiling system

Memphasys Ltd has seen a positive focus on its RoXsta antioxidant profiling system, through the publication of a manuscript on its qualities

16 Jan 2025 10:28 (AEDT)

Sperm tech player Memphasys ships unit to Dubai – but can the stock attract liquidity?

Memphasys (ASX:MEM) has confirmed it's sent a demo unit of its Felix sperm separator system to a hospital in Dubai.

05 Dec 2024 13:42 (AEDT)

Memphasys' (ASX:MEM) FELIX system records 10 new healthy births in India

Memphasys (ASX:MEM) has announced that its patented sperm isolation technology has resulted in 10 new births in India for couples experiencing difficulties conceiving a child.

15 Sep 2023 14:50 (AEST)

Memphasys (ASX:MEM) welcomes first baby born in India using Felix system

Reproductive biotechnology company Memphasys (ASX:MEM) has completed the first commercial sale of its Felix system to a clinic in Japan.

03 Apr 2023 09:56 (AEST)



Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $9.917M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $84.84K 17.61M

Buyers (Bids)

No. Vol. Price($)
2 1066000 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 7314008 12
View Market Depth
Last trade - 15.13pm 23/04/2025 (20 minute delay) ?
MEM (ASX) Chart

Top Stories

Where to find opportunities amid the trade war turmoil

We explore whether it might be time to buy the likes of CBA (ASX:CBA), BHP Group (ASX:BHP), Santos (ASX:STO), and Woodside (ASX:WDS).
From the Outback to the Andes: The experts speak - HotCopper webinar HotCopper's guests and experts discuss why ASX-listed exploration and mining companies are investing in projects in Latin America, where some key jurisdictions are rolling out the welcome mat to foreign investment.
Listen: HotCopper Podcast 010 – The Latin America expansion boom Welcome to this week’s HotCopperWire, our market watch podcast!Each week, HotCopper’s senior markets reporter Jonathon Davidson and I take you through all the week’s biggest news headlines @ and what they mean for Aussie investors.In this Week ...
ASX Market Close: Tariff backpedal pushes ASX towards 8000pts – again The ASX is climbing back towards 8000pts after Trump's tariff wind-back. But that leaves us wondering: what was the point at all?
From the Outback to the Andes: Why ASX-listed miners are moving into Latin America Companies are finding projects in Latin America of a quality they say just isn't available in Australia anymore.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.